Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal

GALWAY, IRELAND--November 6, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has struck a 955 million-euro ($1.1 billion) deal to sell its two travel vaccines to Denmark's Bavarian Nordic (Kvistgaard, Denmark).

Within this article: Details vaccines sale, value of deal, GSK's vaccines division, new products and financial performance.

Subscribe Now!

(All Fields Required)

Fill Out Form To Subscribe +

First Name

Last Name

Email Address

Username

Password

Repeat Password

All Members Receive the Following Resources:

Industry News Digest
Upcoming Webinars
On-Demand Webinars
The NavigatIIR Newsletter
Economic Indicators

View All Member Resources

GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal

Login or Register for Instant Access

Subscribe Now!

Related Articles

All Members Receive the Following Resources: